除激光冠状动脉切除术与远端保护新动脉样硬化破裂:一个案例报告
Nobuhiro Watanabe1, Hiroyuki Yamamoto1, Kunimitsu Kawahara2
1Division of Cardiovascular Medicine, Hyogo Prefectural Harima-Himeji General Medical Center, 3-264 Kamiya-cho, 670-8560 Himeji, Japan.
European heart journal. Case reports
|December 25, 2023
概括
新动脉样硬化断裂导致心肌梗塞. 用远距离保护的排外激光冠状动脉切除术减少了斑块,但更高的设置导致没有回流;用药物涂层的气球血管造形术取得了最佳结果.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 医疗器械 医疗器械
背景情况:
- 新动脉样硬化是支架内静止症 (ISR) 的关键因素,在穿皮冠状动脉干预中构成挑战.
- 排泄激光冠状动脉切除术 (ELCA) 和栓塞保护装置正在探索,以减轻手术期间的远端栓塞.
研究的目的:
- 报告一种导致心肌梗塞的内置新动脉样硬化断裂病例.
- 评估ELCA与远距离保护在管理复杂ISR中的有效性和安全性.
主要方法:
- 一名71岁的男性患有新动脉样硬化裂变相关的心肌梗塞,接受了高级冠心内成像 (IVUS,OCT).
- 最初的ELCA与远距离保护 (Filtrap) 减少了新动脉样硬化体积.
- 随后的高设定ELCA导致过器没有回流;在设备被移除后,进行了药物涂层气球血管整形.
主要成果:
- 冠内成像证实了新动脉样硬化断裂是ISR和潜在的远端栓塞的原因.
- 最初的ELCA有效地减少了斑块负担,但更高的设置导致了无回流现象.
- 药物涂层气球血管整形提供了最佳的结果,没有冠状动脉流动干扰后ELCA.
结论:
- 埃尔卡可以减少斑块和血栓,可能减少远端栓塞.
- 高能量的ELCA设置可能会增加远端栓塞的风险,特别是在动脉压升高时.
- 在ELCA期间的远程保护对于患有显著的新动脉样硬化症的患者来说可能是有益的,以防止冠状动脉流动障碍.
关键词:
案例报告案例报告远距离保护 远距离保护极致激光冠状动脉切除术是什么?实体静脉复缩 (英语:In-stent restenosis) 是一种体内静脉复缩.新动脉样硬化新动脉样硬化.发生斑块破裂.更多相关视频
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023
1.5K
06:26Novel and Innovative Hybrid Technique for Type A Aortic Dissection
Published on: March 28, 2025
292
相关概念视频
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...